A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

Background. Iron deficiency is a common cause of anaemia and hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) in non-dialysis-dependent chronic kidney disease (ND-CKD) patients. Current intravenous iron agents cannot be administered in a single high dose because of adverse effects. Fer...

Descripción completa

Detalles Bibliográficos
Autores principales: Qunibi, Wajeh Y., Martinez, Carlos, Smith, Mark, Benjamin, Joseph, Mangione, Antoinette, Roger, Simon D.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084440/
https://www.ncbi.nlm.nih.gov/pubmed/20929915
http://dx.doi.org/10.1093/ndt/gfq613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084440/
https://www.ncbi.nlm.nih.gov/pubmed/20929915
http://dx.doi.org/10.1093/ndt/gfq613

Ejemplares similares